I-124 PET/CT to Predict the Outcome of Blind I-131 Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET)

The current and evolving role of FDG–PET/CT in personalized iodine‑131 therapy of differentiated thyroid cancer

Leonardo, Pace
Michele, Klain
Luca, Tagliabue
Giovanni, Storto

January 2017

Purpose Several approaches have been recommended for the selection of patients with differentiated t...

Usefulness of I-124 PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with I-131

Pettinato, C.
Monari, F.
Nanni, C.
Allegri, V.
Marcatili, S.
Civollani, S.
Cima, S.
Spezi, Emiliano
Mazzarotto, R.
Fanti, S.

December 2012

AIM: The aim of this work was the evaluation of the usefulness of 124I PET/CT sequential scans t...

Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy

Barbara Salvatore
Michele Klain
Emanuele Nicolai
Domenico D’Amico
Gianluca De Matteis
Marco Raddi
Rosa Fonti
Teresa Pellegrino
Giovanni Storto
Alberto Cuocolo
Leonardo Pace

January 2017

Background: To assess the long-term prognostic value of 18F-fluorodeoxyglucose (FDG) positron emissi...

I-124 PET/CT to Predict the Outcome of Blind I-131 Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer:Results of a Multicenter Diagnostic Cohort Study (THYROPET)

Kist, Jakob W.
de Keizer, Bart
van der Vlies, Manfred
Brouwers, Adrienne H.
Huysmans, Dyde A.
van der Zant, Friso M.
Hermsen, Rick
Stokkel, Marcel P. M.
Hoekstra, Otto S.
Vogel, Wouter V.

May 2016

Patients with suspected recurrence from differentiated thyroid carcinoma, based on an increased thyr...

I-124 PET/CT to Predict the Outcome of Blind I-131 Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET)

Kist, Jakob W.
de Keizer, Bart
van der Vlies, Manfred
Brouwers, Adrienne H.
Huysmans, Dyde A.
van der Zant, Friso M.
Hermsen, Rick
Stokkel, Marcel P. M.
Hoekstra, Otto S.
Vogel, Wouter V.

May 2016

Patients with suspected recurrence from differentiated thyroid carcinoma, based on an increased thyr...

Recurrent differentiated thyroid cancer: Towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): Study protocol of a multicenter observational cohort study

Kist, Manfred
Keizer, Bart
Stokkel, Marcel
Hoekstra, Otto
Vogel, Wouter
Klerk, J. M H
Huysmans, D.
Tinteren, Harm
De Boer, Jan Paul
Morreau, Hans
Vlies, M.
Huisman, Marc
Lentjes, Eef
Smit, Jan
Lavalaye, J.
Jager, Philip
Zant, F.
Hoekstra, Corneline
Gotthardt, Martin
Schelfhout, L.J.
Brouwers, A.
Dijk, A.
Bruin, W.
Al Younis, Imad
Sivro, Senail
Adam, Judit
Phan, H. T T
Sloof, Gerrit
Wagenaar, N. R L
Kam, Boen
Broek, M.R.J.
Smit, F.

June 2014

textabstractBackground: After initial treatment of differentiated thyroid carcinoma (DTC) patients a...

PET/CT in the management of differentiated thyroid cancer

Emilia Zampella
Michele Klain
Leonardo Pace
Alberto Cuocolo

January 2021

tThe standard treatment of differentiated thyroid cancer (DTC) consists of surgery followed by iodin...

The diagnostic value of I-124-PET in patients with differentiated thyroid cancer

Phan, Ha T. T.
Jager, Pieter L.
Paans, Anne M. J.
Plukker, John T. M.
Sturkenboom, M. G. G.
Sluiter, W. J.
Wolffenbuttel, Bruce H. R.
Dierckx, Rudi A. J. O.
Links, Thera P.

May 2008

Background The purpose of this prospective study was to evaluate the clinical diagnostic value of io...

Utility of I-124 PET/CT in identifying radioiodine avid lesions in differentiated thyroid cancer: a systematic review and meta-analysis

Santhanam, Prasanna
Taieb, David
Solnes, Lilja
Marashdeh, Wael
Ladenson, Paul,

May 2017

International audienceIntroduction Diagnostic I-123 scans have been shown to underestimate the disea...

PET-CT Scanning in the Management of Differentiated Thyroid Carcinoma

Pomerri, Fabio
Al Bunni, F.
Muzzio, PIER CARLO

January 2011

Purpose: Differentiated thyroid carcinoma (DTC) has a good prognosis with a 10-year survival rate hi...

STUDY PROTOCOL Open Access Recurrent differentiated th

August 2016

Full list of author information is available at the end of the articlehistopathological features, to...

Long-Term Prognostic Value of the Response to Therapy Assessed by Laboratory and Imaging Findings in Patients with Differentiated Thyroid Cancer

Michele Klain
Emilia Zampella
Leandra Piscopo
Fabio Volpe
Mariarosaria Manganelli
Stefania Masone
Leonardo Pace
Domenico Salvatore
Martin Schlumberger
Alberto Cuocolo

January 2021

This study assessed the long-term predictive value of the response to therapy, evaluated by serum t...

The current and evolving role of FDG–PET/CT in personalized iodine-131 therapy of differentiated thyroid cancer

Pace L.
Klain M.
Tagliabue L.
Storto G.

January 2017

Purpose: Several approaches have been recommended for the selection of patients with differentiated ...

The current and evolving role of FDG–PET/CT in personalized iodine‑131 therapy of differentiated thyroid cancer

Leonardo, Pace
Michele, Klain
Luca, Tagliabue
Giovanni, Storto

January 2017

Purpose Several approaches have been recommended for the selection of patients with differentiated t...

Usefulness of I-124 PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with I-131

Pettinato, C.
Monari, F.
Nanni, C.
Allegri, V.
Marcatili, S.
Civollani, S.
Cima, S.
Spezi, Emiliano
Mazzarotto, R.
Fanti, S.

December 2012

AIM: The aim of this work was the evaluation of the usefulness of 124I PET/CT sequential scans t...

Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy

Barbara Salvatore
Michele Klain
Emanuele Nicolai
Domenico D’Amico
Gianluca De Matteis
Marco Raddi
Rosa Fonti
Teresa Pellegrino
Giovanni Storto
Alberto Cuocolo
Leonardo Pace

January 2017

Background: To assess the long-term prognostic value of 18F-fluorodeoxyglucose (FDG) positron emissi...

I-124 PET/CT to Predict the Outcome of Blind I-131 Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer:Results of a Multicenter Diagnostic Cohort Study (THYROPET)

Kist, Jakob W.
de Keizer, Bart
van der Vlies, Manfred
Brouwers, Adrienne H.
Huysmans, Dyde A.
van der Zant, Friso M.
Hermsen, Rick
Stokkel, Marcel P. M.
Hoekstra, Otto S.
Vogel, Wouter V.

May 2016

Patients with suspected recurrence from differentiated thyroid carcinoma, based on an increased thyr...

I-124 PET/CT to Predict the Outcome of Blind I-131 Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET)

Kist, Jakob W.
de Keizer, Bart
van der Vlies, Manfred
Brouwers, Adrienne H.
Huysmans, Dyde A.
van der Zant, Friso M.
Hermsen, Rick
Stokkel, Marcel P. M.
Hoekstra, Otto S.
Vogel, Wouter V.

May 2016

Patients with suspected recurrence from differentiated thyroid carcinoma, based on an increased thyr...

Recurrent differentiated thyroid cancer: Towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): Study protocol of a multicenter observational cohort study

Kist, Manfred
Keizer, Bart
Stokkel, Marcel
Hoekstra, Otto
Vogel, Wouter
Klerk, J. M H
Huysmans, D.
Tinteren, Harm
De Boer, Jan Paul
Morreau, Hans
Vlies, M.
Huisman, Marc
Lentjes, Eef
Smit, Jan
Lavalaye, J.
Jager, Philip
Zant, F.
Hoekstra, Corneline
Gotthardt, Martin
Schelfhout, L.J.
Brouwers, A.
Dijk, A.
Bruin, W.
Al Younis, Imad
Sivro, Senail
Adam, Judit
Phan, H. T T
Sloof, Gerrit
Wagenaar, N. R L
Kam, Boen
Broek, M.R.J.
Smit, F.

June 2014

textabstractBackground: After initial treatment of differentiated thyroid carcinoma (DTC) patients a...

PET/CT in the management of differentiated thyroid cancer

Emilia Zampella
Michele Klain
Leonardo Pace
Alberto Cuocolo

January 2021

tThe standard treatment of differentiated thyroid cancer (DTC) consists of surgery followed by iodin...

The diagnostic value of I-124-PET in patients with differentiated thyroid cancer

Phan, Ha T. T.
Jager, Pieter L.
Paans, Anne M. J.
Plukker, John T. M.
Sturkenboom, M. G. G.
Sluiter, W. J.
Wolffenbuttel, Bruce H. R.
Dierckx, Rudi A. J. O.
Links, Thera P.

May 2008

Background The purpose of this prospective study was to evaluate the clinical diagnostic value of io...

Utility of I-124 PET/CT in identifying radioiodine avid lesions in differentiated thyroid cancer: a systematic review and meta-analysis

Santhanam, Prasanna
Taieb, David
Solnes, Lilja
Marashdeh, Wael
Ladenson, Paul,

May 2017

International audienceIntroduction Diagnostic I-123 scans have been shown to underestimate the disea...

PET-CT Scanning in the Management of Differentiated Thyroid Carcinoma

Pomerri, Fabio
Al Bunni, F.
Muzzio, PIER CARLO

January 2011

Purpose: Differentiated thyroid carcinoma (DTC) has a good prognosis with a 10-year survival rate hi...

STUDY PROTOCOL Open Access Recurrent differentiated th

August 2016

Full list of author information is available at the end of the articlehistopathological features, to...

Long-Term Prognostic Value of the Response to Therapy Assessed by Laboratory and Imaging Findings in Patients with Differentiated Thyroid Cancer

Michele Klain
Emilia Zampella
Leandra Piscopo
Fabio Volpe
Mariarosaria Manganelli
Stefania Masone
Leonardo Pace
Domenico Salvatore
Martin Schlumberger
Alberto Cuocolo

January 2021

This study assessed the long-term predictive value of the response to therapy, evaluated by serum t...

The current and evolving role of FDG–PET/CT in personalized iodine-131 therapy of differentiated thyroid cancer

Pace L.
Klain M.
Tagliabue L.
Storto G.

January 2017

Purpose: Several approaches have been recommended for the selection of patients with differentiated ...

The current and evolving role of FDG–PET/CT in personalized iodine‑131 therapy of differentiated thyroid cancer

Leonardo, Pace
Michele, Klain
Luca, Tagliabue
Giovanni, Storto

January 2017

Purpose Several approaches have been recommended for the selection of patients with differentiated t...

Usefulness of I-124 PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with I-131

Pettinato, C.
Monari, F.
Nanni, C.
Allegri, V.
Marcatili, S.
Civollani, S.
Cima, S.
Spezi, Emiliano
Mazzarotto, R.
Fanti, S.

December 2012

AIM: The aim of this work was the evaluation of the usefulness of 124I PET/CT sequential scans t...

Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy

Barbara Salvatore
Michele Klain
Emanuele Nicolai
Domenico D’Amico
Gianluca De Matteis
Marco Raddi
Rosa Fonti
Teresa Pellegrino
Giovanni Storto
Alberto Cuocolo
Leonardo Pace

January 2017

Background: To assess the long-term prognostic value of 18F-fluorodeoxyglucose (FDG) positron emissi...

I-124 PET/CT to Predict the Outcome of Blind I-131 Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET)

Abstract

Extracted data

I-124 PET/CT to Predict the Outcome of Blind I-131 Treatment in Patients with Biochemical Recurrence of Differentiated Thyroid Cancer: Results of a Multicenter Diagnostic Cohort Study (THYROPET)

Abstract

Extracted data

Related items

Related items